KETABON
LIVE

Serial Number

79387735

Owner

HMNC Holding GmbH

Attorney

Margaret C. McHugh

Filing Date

Sep 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

KETABON Trademark

Serial Number: 79387735 • Registration: 7699821

KETABON is a trademark filed by HMNC Holding GmbH on September 27, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HMNC Holding GmbH (5 trademarks)

Wilhelm-Wagenfeld-Straße 20

Entity Type: 16

Trademark Details

Filing Date

September 27, 2023

Registration Date

February 25, 2025

Published for Opposition

January 7, 2025

Goods & Services

Medical services; medical diagnostic services, namely, testing and analysis for the presence of mental health conditions and disorders; medical analysis for the diagnosis and treatment of humans; DNA screening for medical purposes; genetic testing for medical purposes; performing genetic tests for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes; medical and healthcare services relating to DNA, genetics and genetic testing, namely, mental health services; genetic counselling; medical laboratory analysis services relating to the treatment of persons for the analysis of samples from patients; medical laboratory analysis services relating to the treatment of persons, namely, conducting clinical laboratory tests for diagnostic or treatment purposes; psychiatric therapy services; provision of personalized health care and medical information; providing information and advice relating to medical and health care services.

Chemical test kits for testing gene samples to identify individuals at risk of developing mental health disorders, for laboratory or research use, other than for medical purposes; chemical diagnostic reagents for industrial use; chemical preparations for scientific diagnostic purposes; diagnostic preparations for scientific or research use.

Pharmaceutical products for treatment of mental health; medical preparations for treatment of mental health; medical diagnostic test strips for use in the field of mental health; preparations for the detection of genetic predispositions for medical purposes; reagents for use in medical genetic testing; diagnostic agents and materials being preparations for medical purposes; diagnostic test materials being test media in the form of strips for measuring mental health disorders for medical use.

Scientific research and laboratory apparatus for analysing genetic information; laboratory equipment and instruments for analysing genetic information, other than for medical purposes; laboratory equipment for analysing genetic information, other than for medical purposes.

Scientific and technological services, namely, research in the field of mental health; DNA screening for scientific research use; providing scientific advice on gene therapy research; scientific research, namely, genetic research; scientific research in the field of gene therapy; genetic engineering services, namely, scientific research in the field of genetic engineering; scientific research in the field of genetics; analytical scientific laboratory services; medical laboratory services; medical laboratory services, namely, performance of laboratory analyses; medical laboratory services, namely, conducting laboratory tests; medical laboratory services, namely, laboratory services for analytical tests; laboratory services; scientific laboratory services; laboratory research in the field of genetics; scientific laboratory services, namely, study of materials in laboratories; scientific laboratory services, namely, conducting laboratory tests and laboratory analysis; scientific research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; research and development services in the field of diagnostic agents; research and development services for the pharmaceutical industry; design of diagnostic instruments and devices.

Apparatus for DNA and RNA analysis for medical purposes; genetic testing apparatus for medical purposes; medical diagnostic apparatus for medical purposes for biomarker testing.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 13, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 24, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 25, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 18, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 18, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2024 RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 18, 2024 CNRT
ASSIGNED TO EXAMINER
May 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 30, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 25, 2024 REPR